- Home
- SMTI vs CRDF Comparison
SMTI vs CRDF Comparison
Compare SMTI & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- CRDF
- Stock Information
- Founded
- SMTI 1982
- CRDF 1999
- Country
- SMTI United States
- CRDF United States
- Employees
- SMTI N/A
- CRDF N/A
- Industry
- SMTI Medical/Dental Instruments
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SMTI Health Care
- CRDF Health Care
- Exchange
- SMTI Nasdaq
- CRDF Nasdaq
- Market Cap
- SMTI 297.2M
- CRDF 288.7M
- IPO Year
- SMTI N/A
- CRDF N/A
- Fundamental
- Price
- SMTI $31.20
- CRDF $3.73
- Analyst Decision
- SMTI Strong Buy
- CRDF Strong Buy
- Analyst Count
- SMTI 2
- CRDF 4
- Target Price
- SMTI $47.00
- CRDF $12.00
- AVG Volume (30 Days)
- SMTI 22.8K
- CRDF 1.2M
- Earning Date
- SMTI 03-25-2025
- CRDF 05-01-2025
- Dividend Yield
- SMTI N/A
- CRDF N/A
- EPS Growth
- SMTI N/A
- CRDF N/A
- EPS
- SMTI N/A
- CRDF N/A
- Revenue
- SMTI $86,672,425.00
- CRDF $683,000.00
- Revenue This Year
- SMTI $35.26
- CRDF N/A
- Revenue Next Year
- SMTI $20.79
- CRDF N/A
- P/E Ratio
- SMTI N/A
- CRDF N/A
- Revenue Growth
- SMTI 33.36
- CRDF 39.96
- 52 Week Low
- SMTI $26.00
- CRDF $2.01
- 52 Week High
- SMTI $39.08
- CRDF $6.38
- Technical
- Relative Strength Index (RSI)
- SMTI 42.00
- CRDF 45.87
- Support Level
- SMTI $32.59
- CRDF $3.65
- Resistance Level
- SMTI $35.69
- CRDF $3.88
- Average True Range (ATR)
- SMTI 1.50
- CRDF 0.26
- MACD
- SMTI 0.14
- CRDF -0.02
- Stochastic Oscillator
- SMTI 17.46
- CRDF 30.00
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").